Optaflu [SEP] manufacturer
Optaflu
Optaflu is a cell culture derived influenza vaccine manufactured by Novartis.
History.
On April 27, 2007 Novartis received a positive opinion supporting European Union approval of Optaflu. It is the first influenza vaccine made in a mammalian cell line, rather than chicken eggs. The vaccine will be manufactured in Holly Springs, North Carolina. The United States government is providing $500 million in construction costs and guaranteed vaccine purchases.
last quarter of the century".
France was the largest stakeholder in the L3S programme; French aerospace manufacturer Aérospatiale served as the prime contractor and held responsibility for performing the integration of all sections of the vehicle, while French engine manufacturer Société Européenne de Propulsion (SEP) provided both the first and second stage engines (the third stage engines were produced by Air Liquide and German aerospace manufacturer MBB). Other major companies involved included the French electronics firm Matra, Swedish manufacturer Volvo, and German aircraft producer Dornier Flugzeugwerke. The